<p><P>Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drug
Biopharmaceutical Drug Design and Development Second Edition
โ Scribed by Susanna Wu-Pong, Yon Rojanasakul
- Publisher
- Humana Press
- Year
- 2008
- Tongue
- English
- Leaves
- 374
- Edition
- Second Edition
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
This book provides a comprehensive examination of the newest biopharmaceutical drugs. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additionally, the volume examines new and emerging technologies, and contains a review of the Human Genome Project.
โฆ Table of Contents
Front......Page 1
Preface......Page 5
Contents......Page 7
Contributors......Page 9
1 Biotechnology: 2008 and Beyond......Page 11
2 The Human Genome Project and Drug Development......Page 25
3 The Use of Bioinformatics and Chemogenomics
in Drug Discovery......Page 40
4 DNA Microarrays in Drug Discovery and Development......Page 55
5 Microarray Technology Using Proteins, Cells, and TIssues......Page 75
6 Pharmacogenetic Issues in Biopharmaceutical Drug Development......Page 106
7 Development and Applications of Transgenics in Biotechnology
and Medicine......Page 128
8 Viral, Nonviral, and Physical Methods for Gene Delivery......Page 147
9 Stem Cell Technology and Drug Development......Page 180
10 Small Nucleic Acid-Based Drug: Successes and Pitfalls......Page 197
11 Therapeutic Strategies Targeting the Innate Antiviral Immune Response......Page 226
12 Pharmacogenetics in the Clinic......Page 255
13 Molecular Modeling: Considerations for the Design
of Pharmaceuticals and Biopharmaceuticals......Page 269
14 Macromolecular Drug Delivery......Page 294
15 Changes in Biologic Drug Approval at FDA......Page 325
16 Follow-On Protein Products: The Age of Biogenerics?......Page 344
Index......Page 366
๐ SIMILAR VOLUMES
<p><p>This volume explores the application of Quality by Design (QbD) to biopharmaceutical drug product development. Twenty-eight comprehensive chapters cover dosage forms, liquid and lyophilized drug products. The introductory chapters of this book define key elements of QbD and examine how these e
The biopharmaceutical market has come along way since 1982 when the first biopharmaceutical product, recombinant human insulin, was launched. <br> Over 120 such products are currently being marketed around the world including nine blockbuster drugs. The global market for biopharmaceuticals, which is
In the last two decades, the discipline of biopharmaceutics has undergone considerable advances, particularly with regard to bioavailability and bioequivalence as they relate to product quality and regulatory standards of approval. Textbooks in the field have not been able to keep up with the growth
In the last two decades, the discipline of biopharmaceutics has undergone considerable advances, particularly with regard to bioavailability and bioequivalence as they relate to product quality and regulatory standards of approval. Textbooks in the field have not been able to keep up with the growth